ImmunoPrecise Antibodies promeut linnovation thrapeutique avec des avances rvolutionnaires sur les anticorps de lapin
IPA Stock | USD 0.41 0.03 7.89% |
About 55% of Immunoprecise Antibodies' investors are presently thinking to get in. The analysis of overall sentiment of trading Immunoprecise Antibodies stock suggests that some investors are interested at this time. The current market sentiment, together with Immunoprecise Antibodies' historical and current headlines, can help investors time the market. In addition, many technical investors use Immunoprecise Antibodies stock news signals to limit their universe of possible portfolio assets.
Immunoprecise |
ImmunoPrecise Antibodies Ltd. , une socit de recherche et de technologie biothrapeutiques axe sur lIA,
Read at businesswire.com
Immunoprecise Antibodies Fundamental Analysis
We analyze Immunoprecise Antibodies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunoprecise Antibodies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunoprecise Antibodies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Immunoprecise Antibodies is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Immunoprecise Antibodies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunoprecise Antibodies stock to make a market-neutral strategy. Peer analysis of Immunoprecise Antibodies could also be used in its relative valuation, which is a method of valuing Immunoprecise Antibodies by comparing valuation metrics with similar companies.
Peers
Immunoprecise Antibodies Related Equities
STTK | Shattuck Labs | 6.93 | ||||
IPSC | Century Therapeutics | 3.85 | ||||
ANNX | Annexon | 3.73 | ||||
CSBR | Champions Oncology | 3.59 | ||||
INAB | In8bio | 3.33 | ||||
CUE | Cue Biopharma | 2.83 | ||||
TCRX | Tscan Therapeutics | 2.65 | ||||
UBX | Unity Biotechnology | 1.68 | ||||
AVTE | Aerovate Therapeutics | 0.75 | ||||
EXAI | Exscientia | 0.00 | ||||
WVE | Wave Life | 0.40 | ||||
ELYM | Eliem Therapeutics | 1.32 | ||||
ZURA | Zura Bio | 1.63 | ||||
RXRX | Recursion Pharmaceuticals | 1.83 | ||||
CGTX | Cognition Therapeutics | 2.44 | ||||
AVIR | Atea Pharmaceuticals | 2.94 | ||||
ANEB | Anebulo Pharmaceuticals | 4.11 | ||||
DRMA | Dermata Therapeutics | 4.35 | ||||
TFFP | Tff Pharmaceuticals | 6.25 |
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |